Dean J H, Twerdok L E, Tice R R, Sailstad D M, Hattan D G, Stokes W S
Sanofi-Synthelabo Research, Sanofi-Synthelabo Inc., Malvern, PA 19355, USA.
Regul Toxicol Pharmacol. 2001 Dec;34(3):258-73. doi: 10.1006/rtph.2001.1497.
The validation status of the murine local lymph node assay (LLNA), a method for assessing the allergic contact dermatitis potential of chemicals, was evaluated by an independent peer review panel (Panel) convened by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The LLNA measures lymphocyte proliferation using incorporation of radioactive thymidine or iododeoxyuridine into cells of the draining lymph nodes of mice topically exposed to a test article. The Panel concluded that the assay performed as well as currently accepted guinea pig methods [guinea pig maximization test (GPMT)/Buehler assay (BA)] for the hazard identification of strong to moderate chemical sensitizing agents, but that it might not correctly identify all weak sensitizers or metals (potential false negative response) or all strong irritants (potential false positive response). The Panel concluded also that the LLNA involves less pain and distress than conventional guinea pig methods. The Panel unanimously recommended the LLNA as a stand-alone alternative for contact sensitization hazard assessment, provided that certain protocol modifications were made. These included collection of individual, rather than pooled, animal response data; the inclusion of a concurrent positive control; and consideration of dose-response information and statistical analyses. A standardized LLNA protocol is provided.
由替代方法验证跨部门协调委员会(ICCVAM)召集的一个独立同行评审小组,对小鼠局部淋巴结试验(LLNA)(一种评估化学品过敏性接触性皮炎潜在可能性的方法)的验证状态进行了评估。LLNA通过将放射性胸苷或碘脱氧尿苷掺入局部暴露于受试物的小鼠引流淋巴结细胞中来测量淋巴细胞增殖。该小组得出结论,在对强至中度化学致敏剂进行危害识别时,该试验的表现与目前公认的豚鼠方法[豚鼠最大化试验(GPMT)/布勒试验(BA)]相当,但它可能无法正确识别所有弱致敏剂或金属(潜在假阴性反应)或所有强刺激物(潜在假阳性反应)。该小组还得出结论,LLNA所涉及的疼痛和痛苦比传统豚鼠方法要少。该小组一致建议,只要对某些方案进行修改,LLNA可作为接触致敏危害评估的独立替代方法。这些修改包括收集个体而非汇总的动物反应数据;纳入同时进行的阳性对照;以及考虑剂量反应信息和统计分析。本文提供了一份标准化的LLNA方案。